NCT05477121View on ClinicalTrials.gov

Severity: Quantifying the Severity of Generalized Tonic-clonic Seizures (GTCS) With Connected Devices

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 12, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
Epilepsy, Generalized
Trial Locations (1)

1011

NeuroDigital@NeuroTech, Lausanne

All Listed Sponsors
lead

Centre Hospitalier Universitaire Vaudois

OTHER

NCT05477121 - Severity: Quantifying the Severity of Generalized Tonic-clonic Seizures (GTCS) With Connected Devices | Biotech Hunter | Biotech Hunter